Compare DRTS & TRUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | TRUP |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2021 | 2014 |
| Metric | DRTS | TRUP |
|---|---|---|
| Price | $14.21 | $30.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $8.67 | ★ $45.80 |
| AVG Volume (30 Days) | ★ 569.0K | 514.2K |
| Earning Date | 05-18-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 295.65 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $1,439,305,000.00 |
| Revenue This Year | N/A | $11.79 |
| Revenue Next Year | $699.98 | $8.83 |
| P/E Ratio | ★ N/A | $114.81 |
| Revenue Growth | N/A | ★ 11.95 |
| 52 Week Low | $3.01 | $21.16 |
| 52 Week High | $14.75 | $49.19 |
| Indicator | DRTS | TRUP |
|---|---|---|
| Relative Strength Index (RSI) | 61.69 | 66.53 |
| Support Level | $6.59 | $24.26 |
| Resistance Level | N/A | $38.25 |
| Average True Range (ATR) | 0.72 | 1.35 |
| MACD | 0.14 | 0.60 |
| Stochastic Oscillator | 84.43 | 88.57 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions. Geographically, the company operates in United States, which derives maximum revenue; and Canada and Others.